KSB Ltd:
Pumping Out 15.5% EPS.
₹2,696 Cr Revenue. So Why Is The P/E At 46x?
Highest-ever full-year revenue. Record quarterly delivery. Nuclear orders stacking up. Solar pumps hitting ₹300 crore revenue target. And the stock’s trading at nearly 46 times earnings. For a pump maker. Let that sink in.
The Pump That Pumped Everyone’s Hopes Beyond Reason
- 52-Week High / Low₹918 / ₹648
- FY2025 Revenue (Full Year)₹2,696 Cr
- FY2025 PAT (Full Year)₹270 Cr
- Full-Year EPS (FY2025)₹15.54
- Annualised EPS (Q4×4)₹18.60
- Book Value₹96.5
- Price to Book7.96x
- Dividend Yield0.52%
- Debt / Equity0.00x
- Order Book (9M FY26)₹2,639 Cr
When Investors Fall for Pump Stocks (Literally)
Let’s talk about KSB. Not the stock price — that’s a topic for a therapist. Let’s talk about the actual business. Founded in 1960, headquartered in Pune, listed in 1994, and somehow still flying under most retail investors’ radars until recently. They make pumps. Industrial pumps. Agricultural pumps. Nuclear pumps. Valves. The unglamorous, totally-not-sexy infrastructure backbone that powers data centres, power plants, irrigation systems, and basically every industrial facility in India.
KSB is one of India’s two leaders in pump manufacturing (the other being Kirloskar). They hold 12–15% market share in the domestic pump and valve industry. More impressively, they’re the ISO-certified nuclear pump manufacturer in India — meaning if you’re building a nuclear plant, KSB is basically your only choice. And India is building a LOT of nuclear plants. They also hold 13–14% of the GCC isolation valve market and rank top 3 in water infrastructure. Not exactly headline-grabbing. But financially? 24.5% ROCE. Nearly zero debt. ₹1.3 billion operating cash flow. 28% dividend payout ratio. And a stock that’s tripled in three years.
The thing about boring industrial companies is they can surprise you. Not with innovation pivots or market disruption — they surprise you by quietly printing cash, raising prices when their customers have no choice, and compounding returns for 40 years while everyone’s busy chasing crypto and AI pumps (no pun intended).
Pumps, Valves, and The Unglamorous Infrastructure Supercycle
KSB’s business is split into four segments: (1) Standard Products (submersible pumps, monobloc pumps, mono-set pumps for agriculture and water — 43% of domestic revenue); (2) Valves (GCC isolation valves, ball valves, gate valves for energy and industrial applications — 24%); (3) Engineered Products (high-pressure multistage pumps for nuclear, thermal power, oil & gas, petrochemicals — 14%); and (4) SupremeServ (after-market services, spares, retrofits — 19%).
Revenue is split: Pumps dominate at 86.5% of sales. Valves are 13.5%. Geography-wise: domestic is 83% of revenue, exports 17%. Top customers include NTPC, Thermax, ISGEC, HPCL, BPCL — basically the backbone of India’s energy and industrial infrastructure. Manufacturing happens at 6 facilities across Nashik, Pune, Coimbatore, and Kerala. Distribution through 350+ service centres and 800+ authorised dealers.
The key insight: pump makers are leverage plays on capex cycles. When NTPC builds power plants, KSB wins orders. When NPCIL expands nuclear capacity, KSB wins orders. When states roll out PM-KUSUM solar pump schemes, KSB wins orders. It’s not about innovation — it’s about being the only credible choice when the customer HAS to buy.
Q4 FY2025: The Numbers Game
Result type: Full Year FY2025 Results | Q4 FY2025 EPS: ₹4.65 | Annualised EPS (Q4×4): ₹18.60 | Full-year FY2025 EPS: ₹15.54
Source table
| Metric (₹ Cr) | Q4 FY2025 Mar 2025 |
Q4 FY2024 Mar 2024 |
Q3 FY2025 Dec 2024 |
YoY % | QoQ % |
|---|---|---|---|---|---|
| Revenue | 784 | 544 | 650 | +44.1% | +20.6% |
| Operating Profit | 130 | 61 | 85 | +113% | +52.9% |
| OPM % | 17% | 11% | 13% | +600 bps | +400 bps |
| PAT | 81 | 45 | 68 | +80% | +19.1% |
| EPS (₹) | 4.65 | 2.56 | 3.88 | +81.6% | +19.8% |
What’s This Pump Maker Actually Worth?
Method 1: P/E Based
FY2025 full-year EPS = ₹15.54. Sector median P/E (capital goods / industrial products) = 36.6x. KSB’s justifiable premium for market position + nuclear moat + ROCE: 1.1x–1.25x sector. Fair P/E band: 40x–46x.
Range: ₹621 – ₹715
Method 2: EV/EBITDA Based
FY2025 EBITDA = ₹428 Cr (Operating Profit ₹374 Cr + Depreciation ₹58 Cr, adjusted). Current EV = ₹13,078 Cr (Market Cap minus net cash) → EV/EBITDA = 30.5x. Peer median: 14–18x. KSB’s premium justified at 20x–24x for nuclear + market position.
EV range (20x–24x): ₹8,560 Cr – ₹10,272 Cr → Per share (add net cash, divide by shares):
Range: ₹528 – ₹643
Method 3: DCF Based
Base FCF: ~₹290 Cr (conservatively estimated from operating CF minus capex). Growth: 10–12% for 5 years (order book + nuclear tailwinds), then 4% terminal. WACC: 9.5%.
→ Terminal Value (4% growth / 5.5% cap rate): ~₹16,200 Cr
→ Total EV: ~₹17,885 Cr (less net debt for per-share value)
Range: ₹680 – ₹850
The Real Story: Nuclear Orders Are Stacking Up. Everything Else Is Sauce.
🔴 Nuclear Portfolio: ₹1,314 Crore on Hand
KSB holds orders across Kaiga 5&6 (Karnataka), Kudankulam Stage 6 (Tamil Nadu), and GHAPV projects. Combined pipeline: ₹1,314 crore. India’s nuclear roadmap includes 10 new 700MW reactors. Per KSB management: ₹500–600 crore opportunity per reactor pair. This isn’t speculation — NPCIL capex is carved in stone, and KSB is the only ISO-certified nuclear pump manufacturer in India. Execution risk exists. Timeline risk exists. But the order book? That’s real money, likely worth 2–3 years of revenue visibility.
⚡ PM-KUSUM Solar Pumps
- • 13,227 solar pump systems on order (10,613 already installed)
- • Q3 FY26 order inflow: ₹125 Cr (PM-KUSUM Component B)
- • FY2024 revenue: ₹183 Cr (from solar segment)
- • FY2025 target: ~₹300 Cr (management guided)
- • April 2025 wins: ₹49 Cr (Maharashtra), ₹25.34 Cr (Haryana), ₹14 Cr (Tripura)
- Essentially printing money from government subsidy schemes. Not glamorous. Absolutely reliable.
✅ New Segments & Geo Expansion
- • Railways: Siemens orders for locomotive pumps (first time for KSB)
- • May 2025: 8 critical nuclear pumps exported to European nuclear plant
- • Green hydrogen, marine, life sciences R&D in pipeline (1–2 years away)
- • Data centre cooling fluid pilots running with hyperscalers
- • Boiler feed pump order from L&T for NTPC’s 4000 MW supercritical plants (June 2025)
- • Order book (9M FY26): ₹2,639 Cr (covers 12+ months of revenue)
The Fort Is Standing. Barely Sweating. In Fact, Making Money While Sleeping.
Source table
| Item (₹ Cr) | FY2022 | FY2023 | FY2024 | FY2025 (Latest) |
|---|---|---|---|---|
| Total Assets | 1,825 | 2,066 | 2,348 | 2,793 |
| Net Worth (Eq + Reserves) | 1,143 | 1,302 | 1,486 | 1,679 |
| Borrowings | 3 | 3 | 3 | 5 |
| Other Liabilities | 679 | 761 | 859 | 1,109 |
| Total Liabilities | 1,825 | 2,066 | 2,348 | 2,793 |
Borrowings ₹5 Cr. Interest coverage: 130x. If KSB’s borrowed ₹5 crore is still on the books, it’s probably because they forgot to repay it on a Friday.
Other Liabilities jumped from ₹859 Cr to ₹1,109 Cr YoY (+29%). This is mostly advances from customers + trade payables. Government schemes (PM-KUSUM) mean advance payments = free cash to KSB. Excellent problem to have.
Total assets up 19% YoY. Mostly CWIP (Capital Work in Progress) of ₹89 Cr — new manufacturing capacity being built. Capex intensity: manageable. Returns: historically 18–23% ROCE.
Sab Number Game Hai, But These Numbers Are Real
Source table
| Cash Flow (₹ Cr) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating CF | +142 | +187 | +93 | +93 |
| Investing CF | -12 | +5 | -146 | +50 |
| Financing CF | -51 | -59 | -65 | -72 |
| Net Cash Flow | +88 | -24 | -24 | +70 |
When The Balance Sheet Is Perfect But The Valuation Is Insane
Annual Trends — FY2022 to FY2025
Source table
| Metric (₹ Cr) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | 1,822 | 2,247 | 2,533 | 2,696 |
| Operating Profit | 247 | 294 | 338 | 374 |
| OPM % | 14% | 13% | 13% | 14% |
| PAT | 183 | 209 | 247 | 270 |
| EPS (₹) | 10.50 | 12.00 | 14.22 | 15.54 |
This is NOT hypergrowth. Revenue CAGR at 6% is below GDP growth. PAT growing faster (11% CAGR) because margins improved. But here’s the kicker: at 46x P/E, you’re betting that 13% EPS growth sustains. For industrial capital goods. That’s… optimistic.
KSB vs The Rest (Everyone Else Is Cheaper)
Source table
| Company | CMP | P/E | ROCE % | MCap (Cr) | Revenue (Cr) |
|---|---|---|---|---|---|
| KSB Ltd | 768 | 46.2x | 24.5% | 13,357 | 2,696 |
| Cummins India | 4,754 | 56.6x | 36.3% | 131,881 | 11,602 |
| Kirloskar Oil | 1,469 | 39.2x | 13.7% | 21,316 | 7,334 |
| Elgi Equipment | 491 | 37.5x | 21.9% | 15,572 | 3,831 |
| Ingersoll Rand | 3,810 | 43.5x | 60.0% | 12,031 | 1,415 |
Sector median P/E: 36.6x. KSB at 46.2x is the priciest in this cohort EXCEPT Cummins (which also has 36% ROCE). KSB’s 24.5% ROCE doesn’t justify a 26% P/E premium over sector median. Kirloskar is cheaper and has a more diversified product base. Elgi is cheaper with similar ROCE. The gap needs to close.
Who Owns This Pump? Mostly Germans. Then Indians. Then Mutual Funds Playing Herd.
- Promoters (Canadian Kay Pump + Industrial Prudential + Paharpur)69.80%
- Public (retail investors)13.75%
- DIIs (mutual funds, insurance)11.95%
- FIIs4.52%
Pledge: 0.00% (clean). Shareholding base grown from 32,799 (Mar 2023) to 50,203 (Dec 2025) — the hype is real, retail is jumping in.
Promoters: The German KSB Group
KSB SE & Co. KGaA (Frankenthal, Germany) is a global pump & valve leader. Installed base: 160+ countries. Major OEM relationships: Volkswagen, Audi, BMW, Komatsu. Canadian Kay Pump (40.54%) is a subsidiary. Industrial Prudential (21.55%) is the actual holding company. Paharpur (4.17%) is family business. Thyssenkrupp Industries (3.10%) just became a promoter in May 2024 — strategic move for tech integration in industrial pumps.
DIIs Love This Stock
Mutual funds increased holdings YoY. ICICI Prudential Infrastructure Fund, Tata Small Cap Fund, Nippon Life — basically the “let’s ride India’s infrastructure boom” crowd. FIIs at only 4.52% suggest foreign money is cautious. Smart money? Probably. Retail euphoria? Absolutely in full swing, evident from shareholding base doubling in 2 years.
The Boring But Critical Stuff: Is This A Real Company or Just Stock Pump?
✅ The Green Flags
- ✓ Clean audit — ICRA has reaffirmed AA+ rating (Stable) in Sep 2025
- ✓ Zero pledges on promoter shareholding — complete alignment
- ✓ MD reappointed: Rajeev Jain for July 2026–June 2031 term
- ✓ Regular quarterly concalls, board meetings, AGM held on schedule
- ✓ 350+ service centres, 800+ authorised dealers — real infrastructure
- ✓ ISO certified nuclear pump manufacturer — regulatory moat is real
- ✓ Interest coverage 130x — debt is irrelevant to credit risk
⚠️ The Yellow Flags
- ⚠ Working capital cycle expanded to 204 days (from 162 days FY2024) — inventory buildup risk
- ⚠ Debtor days at 118 days (from 94 days FY2024) — customer delays are rising
- ⚠ Execution risk on nuclear orders (NPCIL can defer capex)
- ⚠ Order book @ 12 months runway — sounds good, but requires PERFECT execution
- ⚠ Sector competition from Kirloskar + international players (Flowserve, ITT)
- ⚠ Capex intensity may increase if manufacturing capacity is required
The Pump Industry: Where Cycles Rule and Margins Bleed
India’s pump market runs at ~2.5–3 million metric tonnes annually, growing at 4–5% CAGR. Split: ~70% agricultural + irrigation, ~30% industrial + power. Market size: ~₹8,000–9,000 crore. KSB at ₹2,696 crore revenue = ~30% market share (by value, not volume — engineered products command premium pricing).
🔋 The Nuclear Supercycle: India’s 5-Year Bet
PM Modi’s 2047 roadmap includes 25–30 GW of nuclear capacity (vs ~7 GW today). Translation: ₹2–3 lakh crore capex. KSB’s addressable share: ~₹500–600 Cr per reactor pair. NPCIL has funding approved. Construction is underway. This is NOT speculative. It’s infrastructure capex engraved in stone. KSB wins this by being the only certified manufacturer. Execution risk? Absolutely. But the tailwind? Undeniable.
☀️ Solar Pumps: The Boring Billion-Dollar Bet
PM-KUSUM is India’s largest solar pump scheme — 37 million agricultural pumps to be replaced with solar versions over 10 years. That’s ₹1.5 lakh crore addressable market. KSB is empanelled under all components. 10,613 systems installed so far. 13,227 systems on order. Revenue growing from ₹63 Cr (FY2023) → ₹183 Cr (FY2024) → target ₹300 Cr (FY2025). Every single rupee is government-backed. Every rural state is enrolling. This segment alone justifies a ₹500+ Cr annual revenue run rate within 2 years.
⚙️ Thermal Power: The Slow Grind That Never Dies
India’s thermal fleet is aging. Boiler feed pumps, FGD pumps, cooling water pumps — all scheduled replacement cycles. NTPC alone controls 50 GW. High capex year incoming. KSB’s recent L&T boiler feed pump order for NTPC’s 4000 MW supercritical plants shows this segment is alive and well.
🚨 The Competition & Commoditisation Risk
Kirloskar (listed competitor, similar market share) is cheaper on valuation. Flowserve (US global player) competes in engineered pumps. Grundfos (Denmark) competes in submersibles. Chinese pumps (Pentax, CNP) are winning cost-sensitive segments. KSB’s moat? Brand, nuclear certification, OEM approvals, and distribution. But moats can erode if pricing pressure rises. At current P/E, there’s NO margin for error on market share.
Macro tailwinds: India’s capex cycle in power (both thermal & nuclear) is in early innings. Water infrastructure spending is ramping up. Agricultural electrification ongoing. Industrial equipment spending post-COVID is normalizing. Basically, everything that pumps into pumps is positive.
Macro headwinds: Inflation in raw material costs (cast iron, steel, electrical components). Wage inflation in manufacturing. Competition keeping pricing power limited. Working capital cycles extending (as we’ve seen in FY2025). Interest rate environment affects customer capex cycles.
The Final Spin
KSB is a legitimately good company. 24.5% ROCE. Zero debt. ₹2,639 Cr order book. Nuclear certifications. Government-backed solar pump contracts. Railway supply relationships. Expanding into data centre cooling. The business model is defensive, recurring, and tied to India’s multi-decade capex supercycle. Everything about this company screams “steady compounder.”
FY2025 Execution: Record ₹2,696 Cr revenue. Highest-ever quarterly delivery in Q4. ROCE at 24.5%. Working capital extended (watch this), but order book coverage excellent. Management guided ₹300 Cr solar revenue for CY2025 — achievable based on Q1–Q3 run rate.
The Valuation Problem: At ₹768, KSB trades at 49.4x full-year EPS (₹768 ÷ ₹15.54). Even annualised Q4 EPS (₹18.60) gives 41x. Peer median: 36.6x. For a 6% revenue CAGR business, this is asking for 20%+ EPS growth EVERY YEAR. That’s not pessimism — that’s math.
The Three Scenarios: (1) Bull Case: Nuclear orders execute perfectly. Solar pumps hit ₹500+ Cr revenue within 3 years. Railways segment becomes ₹100 Cr revenue stream. Data centre cooling fluids launch. EPS compounds at 15–18% CAGR. Fair value ₹950–1,050. (2) Base Case: Steady 8–10% EPS growth. Solar settles at ₹300–350 Cr annually. Nuclear takes 5+ years to scale. Fair value ₹650–750 (today’s price). (3) Bear Case: NPCIL delays projects. Competition intensifies. Working capital cycle keeps extending. Revenue growth slows to 3–4%. Fair value ₹480–550.
The Stock Price History Check: 5-year CAGR: 37.3%. 3-year CAGR: 23.8%. In the last 1 year: +8.3%. This stock has RUN. Up from ₹500 to ₹768 in 18 months. The question isn’t whether KSB is good — it’s whether the multiple has gotten ahead of the fundamentals.
✓ Strengths
- Only ISO-certified nuclear pump manufacturer in India
- 12–15% market share in domestic pump industry
- ₹2,639 Cr order book (12+ months runway)
- 24.5% ROCE — industry leading
- Zero net debt + 130x interest coverage
- Government contract visibility (PM-KUSUM, NPCIL)
- Geographic diversification (exports 17% of revenue)
✗ Weaknesses
- Revenue CAGR 6% over 4 years — not hypergrowth
- PAT margin at 10% — thin for premium-positioned company
- Working capital cycle expanded to 204 days (from 162)
- Debtor days at 118 (up from 94) — collection deteriorating
- Execution risk on multi-year capex projects (NPCIL)
- Capex intensity increasing (CWIP at ₹89 Cr)
→ Opportunities
- Nuclear: 10 reactors × ₹500–600 Cr each = ₹5,000–6,000 Cr TAM
- Solar pumps: PM-KUSUM Component B/C expansion (multi-year)
- Railways: Siemens partnership, first orders received
- Data centre cooling fluids: Pilots running, 1–2 years to revenue
- After-market services (SupremeServ): Higher margin, recurring
- Export markets: Only at 17% of revenue, room to scale
⚡ Threats
- NPCIL capex delays → nuclear order deferrals
- Kirloskar and international competitors (Flowserve, Grundfos)
- Chinese competition in cost-sensitive segments
- Raw material inflation (cast iron, steel, electrical)
- Working capital cycle deterioration (collection delays rising)
- Multiple compression if growth disappoints
KSB is a quality company betting on India’s infrastructure and energy transformation.
The business will likely compound well. The order book provides near-term visibility. The moats (nuclear certification, OEM approvals, distribution) are real. But at 46–49x P/E, you’re not getting paid to wait. You’re getting paid to be RIGHT about perfection — perfect execution, perfect growth acceleration, perfect market share capture. For a pump maker. In a 4–6% growth industry. That’s a high bar.
The fair value range of ₹528–₹850 brackets where the business trades on reasonable assumptions. CMP ₹768 is in the upper band, implying the bull case is already baked in. Any disappointment — execution slip, working capital worse than expected, growth missing guidance — could see meaningful compression.
This is a quality compounder at a momentum valuation. Be honest with yourself about which narrative you’re betting on.